Saliva test may unlock personalized obesity treatment
NCT ID NCT06814938
First seen Mar 26, 2026 · Last updated May 10, 2026 · Updated 5 times
Summary
This study tests whether a simple saliva test can predict how well people with obesity will respond to the weight-loss drug semaglutide. Researchers will compare weight loss in participants who have a specific biomarker in their saliva versus those who don't. The goal is to make obesity treatment more personalized and effective.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Mayo Clinic in Florida
RECRUITINGJacksonville, Florida, 32224, United States
-
Mayo Clinic in Rochester
RECRUITINGRochester, Minnesota, 55905, United States
Conditions
Explore the condition pages connected to this study.